Indian J Med Microbiol
. 2021 May 26;S0255-0857(21)04111-6.
doi: 10.1016/j.ijmmb.2021.05.009. Online ahead of print.
Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India
Hardeva Ram Nehara 1 , Inder Puri 2 , Vipin Singhal 3 , Sunil Ih 3 , Bhagirath Ram Bishnoi 4 , Pramendra Sirohi 3
Affiliations
- PMID: 34052046
- PMCID: PMC8153224
- DOI: 10.1016/j.ijmmb.2021.05.009
Abstract
Coronavirus disease 2019 (COVID-19), may present with a myriad of clinical manifestations and complications. Patients with COVID-19 are at increased risk of pulmonary thromboembolism, acute cardiac injury, arrhythmias, acute stroke, and secondary infections. Mucormycosis is a catastrophic fungal infection characterized by vascular invasion, thrombosis, and necrosis of tissues. We report five cases of COVID-19 infection, who developed rhino-orbital mucormycosis, during the course of treatment. Early recognition of this life-threatening infection is the key to allow for optimal treatment and improved outcomes.
Keywords: COVID-19; Mucormycosis; Rajasthan.